Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the 6th Board of Directors
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the First Meeting of the 6th Special Meeting of Independent Directors
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement on the need to issue a report on the use of funds raised previously
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Notice on not being penalized or taken regulatory measures by the securities regulatory authorities or the stock exchange in the last five years
Qianhong Pharmaceutical: Qianhong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the 6th Board of Supervisors
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: October 17, 2024 Investor Relations Activity Record
Qianhong Pharmaceuticals: Qianhong Pharmaceuticals: Announcement on Proposed Renewal of the Accounting Firm for 2024
Qianhong Pharmaceutical: Announcement of Board Resolutions
Qianhong Pharmaceutical: Announcement of Supervisory Committee Resolutions
Qianhong Pharmaceutical: 2024-033 Qianhong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Directors
Changzhou Qianhong Biopharma: Announcement of Board of Directors' resolution for semi-annual report.
Changzhou Qianhong Biopharma: 002550 Qianhong Pharmaceutical performance briefing, roadshow event information 20240509
Changzhou Qianhong Biopharma: 002550 Qianhong Pharmaceutical Research Activity Information 20240426
Changzhou Qianhong Biopharma: Announcement of Board Resolutions
Changzhou Qianhong Biopharma: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Changzhou Qianhong Biopharma: Internal Control Audit Report
Changzhou Qianhong Biopharma: Independent Director's Annual Debriefing Report
Changzhou Qianhong Biopharma: Announcement of Supervisory Board Resolutions
Changzhou Qianhong Biopharma: Independent Director's 2023 Debriefing Report (Ren Shengxiang)
Changzhou Qianhong Biopharma: Independent Director's 2023 Debriefing Report (Xu Guanghua)